Skip to main content
logo
Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.7500
-0.0500 (-6.25%)
At close: Oct 15, 2026

Protagenic Therapeutics Balance Sheet

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025
Period Ending
Jun '26 Mar '26 Mar '25
Cash & Equivalents
0.571.510.01
Cash & Short-Term Investments
0.571.510.01
Cash Growth
-86.18%10285.92%-
Other Receivables
--0.07
Receivables
--0.07
Inventory
--0
Prepaid Expenses
0.140.03-
Total Current Assets
0.711.540.09
Property, Plant & Equipment
0.010.01-
Long-Term Deferred Charges
2.082.09-
Total Assets
2.83.650.09

Liabilities

Fiscal Year
TTMFY 2026FY 2025
Period Ending
Jun '26 Mar '26 Mar '25
Accounts Payable
10.950.96
Accrued Expenses
0.070.080.25
Short-Term Debt
--2.45
Other Current Liabilities
--1.38
Total Current Liabilities
1.071.035.04
Total Liabilities
1.071.035.04

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025
Period Ending
Jun '26 Mar '26 Mar '25
Common Stock
00-
Additional Paid-In Capital
7.066.990.46
Retained Earnings
-4.99-4.03-5.4
Comprehensive Income & Other
-0.34-0.34-0.01
Shareholders' Equity
1.722.62-4.95
Total Liabilities & Equity
2.83.650.09

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025
Period Ending
Jun '26 Mar '26 Mar '25
Total Debt
--2.45
Net Cash (Debt)
0.571.51-2.43
Net Cash Growth
580.43%--
Net Cash Per Share
0.300.65-0.45
Filing Date Shares Outstanding
1.811.815.3
Total Common Shares Outstanding
1.811.815.3
Working Capital
-0.360.51-4.95
Book Value Per Share
0.951.45-0.93
Tangible Book Value
1.722.62-4.95
Tangible Book Value Per Share
0.951.45-0.93
Machinery
0.150.16-